Continuous Augmentation of Governance Structure The Board of Great Bay Bio Welcomes a New Member
Summary
Mr. Kung graduated from York University in Canada with master degree in economics, and is currently an AICPA (American Institute of Certified Public Accountant). On Mr. Kung directorship, Mr. Kingsley Leung said, "Mr. Kung’s arrival is well-timed, his strong finance background and network with PRC and international investors will certainly help our planned fund raising event later this year. We want to effectively integrate global capital markets, biopharmaceutical industry, and new technologies to help solve growing problems in drug development, such as low R&D productivity. The company has a strong existing track record of developing customized CMC packages for products entering NDA stage, some of which are national class I projects of innovative biological New drugs. The CMC platform encompasses an area of over 3100 square meter, and has a whole set of advanced biopharmaceutical research and development hardware and facilities, with key equipment from well-class brands such as Sartorius, Bio-Rad, GE Healthcare, and Waters.